79346632

Information

  • Trademark
  • 79346632
  • Serial Number
    79346632
  • Registration Number
    7532408
  • Filing Date
    May 20, 2022
    2 years ago
  • Registration Date
    October 15, 2024
    2 months ago
  • Transaction Date
    October 15, 2024
    2 months ago
  • Status Date
    October 15, 2024
    2 months ago
  • Published for Opposition Date
    July 30, 2024
    5 months ago
  • Location Date
    October 14, 2024
    2 months ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    PERKINS, ELLEN
  • Attorney Docket Number
    ALBU 2307993
    Attorney Name
    Karen Lim
  • Owners
Mark Drawing Code
2
Case File Statements
  • GS0411: Education, namely, classes, seminars, and workshops in the fields of biology, medicine, biologicals, biopharmaceuticals, pharmaceuticals, and chemical analysis; providing of training in the fields of biology, medicine, biologicals, biopharmaceuticals, pharmaceuticals, and chemical analysis; teaching and training in the fields of biology, medicine, biologicals, biopharmaceuticals, pharmaceuticals and chemical analysis; teaching and training in the fields of development and use of vaccines, growth factors, immune modulators, monoclonal antibodies, cells, cell therapies, tissues, proteins, recombinant proteins, nucleic acids, gene therapies, products derived from living culture systems, products derived from human blood, products derived from plasma; provision of medical, biological, biopharmaceutical, pharmaceutical and chemical instruction courses; organization of educational conferences in the fields of medical, biological, biopharmaceutical, pharmaceutical and chemical research and development; technical training in the field of medical, biological, biopharmaceutical, pharmaceutical and chemical analysis; information, consultancy and advisory services for the aforementioned services
  • DM0000: The mark consists of a red hexagon with curved corners. The hexagon has a portion of its center and bottom left edge removed in the shape that resembles an albumin protein. The color white represents background and is not part of the mark.
  • CC0000: The color(s) red is/are claimed as a feature of the mark.
  • GS0451: Regulatory compliance auditing; regulatory compliance consultancy in the field of biotechnology, pharmaceuticals, biopharmaceuticals, and medical testing and research; reviewing standards and practices to assure compliance with laws and regulations in the fields of biology, pharmaceuticals, biopharmaceuticals, chemicals, and medicine; information, consultancy and advisory services for the aforementioned services
  • GS0421: Research and development services in the field of new biological, pharmaceutical, biopharmaceutical, chemical and medical products; technological consultancy, namely, providing consultancy and expert assistance in the field of new product development of medicines and pharmaceutical products, and laboratory analysis in the field of medicines and pharmaceuticals; research, development and laboratory analysis services relating to pharmaceutical and medicinal goods, in particular, albumin, chemicals, peptides, proteins, antibodies, cells, nucleic acids, viruses, live viruses, live-attenuated viruses, attenuated viruses, virus-like particles and viral vectors; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control in the field of pharmaceutical, biopharmaceutical, chemical, and medical products; certification, namely, quality control services in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; certification, namely, quality assurance services in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; process monitoring, namely, quality assurance in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; quality control services for others in the field of development and testing of cells; services of a scientific, chemical and biological laboratory; development and testing of chemical, pharmaceutical, biopharmaceutical, chemical and medical production methods; quality control services for others and authentication services in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; process monitoring, namely, providing quality assurance services in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; scientific and medical laboratory services; information, consultancy and advisory services for the aforementioned services
Case File Event Statements
  • 8/4/2022 - 2 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 8/5/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 8/9/2022 - 2 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 1/29/2023 - a year ago
    4 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 3/7/2023 - a year ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/15/2023 - a year ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/16/2023 - a year ago
    7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 4/2/2023 - a year ago
    8 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 5/4/2023 - a year ago
    9 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 5/4/2023 - a year ago
    10 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 5/24/2023 - a year ago
    11 - REFUSAL PROCESSED BY IB Type: RFNT
  • 11/3/2023 - a year ago
    12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/3/2023 - a year ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/3/2023 - a year ago
    14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/10/2024 - 11 months ago
    19 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 12/31/2023 - a year ago
    15 - FINAL REFUSAL WRITTEN Type: CNFR
  • 12/31/2023 - a year ago
    16 - FINAL REFUSAL E-MAILED Type: GNFR
  • 12/31/2023 - a year ago
    17 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 1/10/2024 - 11 months ago
    18 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 1/29/2024 - 11 months ago
    20 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 6/24/2024 - 6 months ago
    22 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/24/2024 - 6 months ago
    23 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/24/2024 - 6 months ago
    21 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 6/25/2024 - 6 months ago
    24 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/10/2024 - 5 months ago
    25 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/30/2024 - 5 months ago
    26 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/30/2024 - 5 months ago
    27 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 10/15/2024 - 2 months ago
    28 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 10/15/2024 - 2 months ago
    29 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC